Novo Nordisk (NVO) P/S (1999 - 2026)
Novo Nordisk (NVO) P/S from Nov 1, 1999 to Jul 21, 2026. The TTM Novo Nordisk (NVO) P/S is 4.28. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Novo Nordisk (NVO)
| Year | P/S | Change |
|---|---|---|
| 2026 | 4.28 | -9.83% |
| 2025 | 4.74 | -48.30% |
| 2024 | 9.18 | -38.80% |
| 2023 | 14.99 | +16.92% |
| 2022 | 12.82 | +9.91% |
| 2021 | 11.67 | +41.17% |
| 2020 | 8.26 | +10.20% |
| 2019 | 7.50 | +18.50% |
| 2018 | 6.33 | -19.32% |
| 2017 | 7.84 | +43.60% |
| 2016 | 5.46 | -42.02% |
| 2015 | 9.42 | +332.36% |
| 2014 | 2.18 | +13.26% |
| 2013 | 1.92 | +10.86% |
| 2012 | 1.74 | +36.09% |
| 2011 | 1.28 | +0.10% |
| 2010 | 1.27 | +71.14% |
| 2009 | 0.74 | +19.84% |
| 2008 | 0.62 | -22.69% |
| 2007 | 0.80 | +53.28% |
| 2006 | 0.52 | +114.98% |
| 2005 | 0.24 | +3.72% |
| 2004 | 0.24 | +32.47% |
| 2003 | 0.18 | +41.73% |
| 2002 | 0.13 | -27.93% |
| 2001 | 0.17 | +13.28% |
| 2000 | 0.15 | +36.93% |
| 1999 | 0.11 | N/A |
Comparison Novo Nordisk (NVO) P/S with competitors
Novo Nordisk (NVO) P/S is 4.28.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -86.56% |
| GRFS | Grifols SA | 0.67 | -84.31% |
| AMRN | Amarin Corp | 1.39 | -67.51% |
| SCLX | Scilex Holding Company | 1.92 | -55.24% |
| SNY | Sanofi | 2.18 | -48.97% |
| PFE | Pfizer Inc | 2.18 | -48.97% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -43.92% |
| BIIB | Biogen Inc | 2.93 | -31.51% |
| GSK | GSK Plc | 3.22 | -24.64% |
| MRK | Merck & Co Inc | 4.54 | +6.03% |
| AZN | Astrazeneca plc | 4.58 | +7.18% |
| AMGN | AMGEN Inc | 5.15 | +20.39% |
| GILD | Gilead Sciences Inc | 5.43 | +26.93% |
| JNJ | Johnson & Johnson | 6.34 | +48.20% |
| ABBV | Abbvie Inc | 7.15 | +67.14% |
| LLY | Lilly(Eli) & Company | 14.28 | +233.81% |